Israel Englander Corbus Pharmaceuticals Holdings, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.31 $57,346 - $1.79 Million	-337,332 Reduced 96.68%	11,585 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $30,477 - $76,920	-145,133 Reduced 29.38%	348,917 $88,000
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $56,852 - $119,034	-177,663 Reduced 26.45%	494,050 $263,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.11 $2,637 - $4,878	-4,395 Reduced 0.65%	671,713 $414,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $572,537 - $1.03 Million	-566,869 Reduced 45.61%	676,108 $690,000
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $1.73 Million - $2.75 Million	1,242,977 New	1,242,977 $2.28 Million
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $22,713 - $61,166	-17,885 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $16,811 - $33,802	17,885 New	17,885 $22,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $720,288 - $4.5 Million	-480,192 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $2.13 Million - $3.73 Million	443,982 Added 1226.13%	480,192 $4.03 Million
Q1 2020 May 14, 2020	BUY	$3.44 - $7.21 $124,562 - $261,074	36,210 New	36,210 $190,000
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $3.67 Million - $5.34 Million	-754,061 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$6.6 - $7.8 $3.71 Million - $4.38 Million	561,739 Added 292.08%	754,061 $5.23 Million
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $1.09 Million - $1.29 Million	164,991 Added 603.68%	192,322 $5.25 Million
Q1 2019 May 14, 2019	SELL	$5.76 - $8.95 $592,784 - $921,080	-102,914 Reduced 79.02%	27,331 $190,000
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $526,268 - $797,406	100,051 Added 331.36%	130,245 $761,000
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $570,722 - $975,751	-122,736 Reduced 80.26%	30,194 $228,000
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $772,296 - $1.04 Million	152,930 New	152,930 $772,000
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $3.16 Million - $5.21 Million	-563,657 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$6.6 - $7.78 $1.95 Million - $2.3 Million	-295,289 Reduced 34.38%	563,657 $4 Million
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $4.94 Million - $6.66 Million	858,946	858,946 $6.14 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account